A股收評:繼續調整!滬指平收,維生素、糧食種植板塊爆發
A股三大指數今日持續調整,截至收盤,滬指平收報2869點,深證成指跌0.04%,創業板指跌0.54%。超2700股下跌,逾2300股上升,全天成交6199億元。盤面上,德國化工巨頭巴斯夫一工廠因火災停產產品影響交付,維生素板塊爆發,東北製藥、爾康製藥等多股升停;五部門實施金融保障糧食安全專項行動,糧食概念、農業種植等板塊走強,神農種業20%升停;ST板塊走高,ST百利等二十餘股升停;預製菜、化學制藥及食品飲料等板塊升幅居前。另外,教育板塊重挫,中公教育、昂立教育雙雙跌停;航天航空、商業航天板塊走低,洪都航空跌停;北斗導航板塊走弱,上海滬工跌停;6G概念、大飛機及軍工等板塊跌幅居前。

Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.